Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_DD8901DF61B3
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
UNIL/CHUV
Title
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
Journal
Nature Reviews. Cancer
Author(s)
Bowtell D.D., Böhm S., Ahmed A.A., Aspuria P.J., Bast R.C., Beral V., Berek J.S., Birrer M.J., Blagden S., Bookman M.A., Brenton J.D., Chiappinelli K.B., Martins F.C., Coukos G., Drapkin R., Edmondson R., Fotopoulou C., Gabra H., Galon J., Gourley C., Heong V., Huntsman D.G., Iwanicki M., Karlan B.Y., Kaye A., Lengyel E., Levine D.A., Lu K.H., McNeish I.A., Menon U., Narod S.A., Nelson B.H., Nephew K.P., Pharoah P., Powell D.J., Ramos P., Romero I.L., Scott C.L., Sood A.K., Stronach E.A., Balkwill F.R.
ISSN
1474-1768 (Electronic)
ISSN-L
1474-175X
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
15
Number
11
Pages
668-679
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
Abstract
High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
OAI-PMH
oai:serval.unil.ch:BIB_DD8901DF61B3
DOI
10.1038/nrc4019
Pubmed
26493647
Web of science
000363691100007
Create date
24/11/2015 18:11
Last modification date
20/08/2019 17:02
Usage data